The Asian Development Bank (ADB) will give USD 940 million in loans to Bangladesh for procuring safe and effective vaccines against Covid-19. An agreement was signed on Thursday in this regard. Read:Govt, ADB ink 250 mln loan deal to strengthen social resilience program Economic Relations Division (ERD) secretary Fatima Yasmin and ADB Country Director Manmohan Parkash signed the loans agreement on behalf of Bangladesh and ADB respectively at a simple ceremony at the ERD in Dhaka. The package, which comprises a regular loan and a concessional loan of $470 million each, is part of ADB’s $9 billion Asia Pacific Vaccine Access Facility (APVAX) launched in December 2020 to offer rapid and equitable vaccine-related support to ADB’s developing member countries (DMCs), according to a release from ADB. The project will fund the purchase of an estimated 44.7 million doses of Covid-19 vaccines to be administered to more than 20 million Bangladeshis by 2024, contributing to the government’s National Deployment and Vaccination Plan for Covid-19 Vaccines. The vaccines will be secured through the Covid-19 Vaccines Global Access (COVAX) program, the United Nations Children’s Fund (UNICEF), or bilateral arrangements with vaccine manufacturers or distributors. Vaccines eligible for financing must meet at least one of the APVAX eligibility criteria: the vaccine has been selected for procurement through the COVAX mechanism; the vaccine has been prequalified by the World Health Organization (WHO) or WHO emergency use listing; or the vaccine has received regular or emergency licensure or authorization by a Stringent Regulatory Authority. Read:ADB approves $250 million loan to Dhaka to finance reforms ADB Country Director Manmohan Parkash said that Safe and effective mass vaccination is critical for protecting lives and livelihoods, and ensuring quick socio-economic recovery from the COVID-19 pandemic. “This is our single largest support for vaccine procurement till now, and ADB is committed to help the government of Bangladesh in procuring quality and affordable vaccines early.” He also mentioned that Vaccines can reduce virus transmission and infection, and curtail mortality, contributing to saving lives and alleviating pressures on the health system. “In addition to vaccine procurement, we are also pleased to help improve the vaccine registration, delivery, distribution, monitoring, coordination, and management systems,” Parkash said. “The assistance follows our reoriented program priorities in supporting a quick socio-economic recovery in Bangladesh,” he added. Read: Climate Change to get priority in Bangladesh alongside Covid support:ADB ADB is helping the government strengthen its vaccine delivery system and fight against COVID-19 through ongoing technical assistance projects worth around $7 million. In addition, ADB has supported Bangladesh’s Covid-19 response through a $250 million loan in June 2021 to strengthen social protection and resilience programs, a $500 million loan in May 2020 for expanding social safety nets for vulnerable groups and supporting critical labor-intensive industries and small and medium enterprises to preserve jobs, a $100 million loan in April 2020 to support procurement of equipment and supplies and upgrading of health and testing facilities,  a $50 million loan for microenterprise development for creating jobs, an initial emergency grant of $350,000 for the procurement of medical supplies and equipment, and $1.3 million from an ongoing project to provide one-time cash support to trainees of an ongoing skills training program.

Asian Development Bank (ADB) has launched a $9 billion Asia Pacific Vaccine Access Facility (APVAX) vaccine initiative offering rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines. More than 14.3 million positive cases have been identified in Asia and the Pacific, causing more than 200,000 deaths, according to a release from the ADB. As the pandemic persists, economic growth in developing Asia is projected to contract by 0.4% in 2020—the first regional gross domestic product contraction since the early 1960s. Promoting safe, equitable, and effective access to vaccines is a top priority for ADB’s COVID-19 response efforts. Vaccination programs can break the chain of virus transmission, save lives, and mitigate the negative economic impacts of the pandemic by restoring confidence in people’s ability to work, travel, and socialize safely. The APVAX provides a comprehensive framework and resource envelope for supporting developing Asia’s vaccine access, using two complementary components. The Rapid Response Component will provide timely support for critical vaccine diagnostics, procurement of vaccines, and transporting vaccines from the place of purchase to ADB’s developing members. The Project Investment Component will support investments in systems for successful distribution, delivery, and administration of vaccines along with associated investments in building capacity, community outreach, and surveillance. This may include such areas as cold-chain storage and transportation, vehicles, distribution infrastructure, processing facilities, and other physical investments. The component may also be used to develop or expand vaccine manufacturing capacity in developing members.